Stéphane Bancel defended his melanoma data and argued that rivals can’t easily copy the technology.
Here’s Why Moderna’s CEO Isn’t Fazed by Its Cancer-Vaccine Selloff
Discover more from UM LEGACY PRESS LTD
Subscribe to get the latest posts sent to your email.